Nuzenio

Hsct

Hsct news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 03 Aug 2026 19:38:51 GMTpDC-AML: consider early allogeneic HSCT to offset poor prognosis - Vera Health
Mon, 27 Jul 2026 16:42:15 GMTLate complications after autologous HSCT for autoimmune diseases: a retrospective survey from the autoimmune diseases working party (ADWP), transplant complications working party (TCWP) and paediatric diseases working party (PDWP) of the european - Nature
Mon, 27 Jul 2026 14:52:19 GMTAstraZeneca’s HSCT-TMA drug misses main endpoint - EMJ
Mon, 27 Jul 2026 11:28:04 GMTUltomiris fails to beat placebo in adult HSCT-TMA trial, narrowing approval path to children - AllSci
Mon, 27 Jul 2026 07:00:00 GMTMixed Ultomiris HSCT-TMA results at AstraZeneca (NASDAQ: AZN) spur paediatric filings - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Hsct.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.